* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download bio-of-cells-lent-restriction-enzymes-information-for-exam
Metagenomics wikipedia , lookup
Human genetic variation wikipedia , lookup
Minimal genome wikipedia , lookup
DNA vaccination wikipedia , lookup
United Kingdom National DNA Database wikipedia , lookup
Transposable element wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Mitochondrial DNA wikipedia , lookup
Oncogenomics wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
DNA damage theory of aging wikipedia , lookup
Nucleic acid double helix wikipedia , lookup
SNP genotyping wikipedia , lookup
Zinc finger nuclease wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
DNA supercoil wikipedia , lookup
Genealogical DNA test wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Molecular cloning wikipedia , lookup
Extrachromosomal DNA wikipedia , lookup
Whole genome sequencing wikipedia , lookup
Frameshift mutation wikipedia , lookup
Genetic engineering wikipedia , lookup
Human genome wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Human Genome Project wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Genome (book) wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Epigenomics wikipedia , lookup
Public health genomics wikipedia , lookup
Designer baby wikipedia , lookup
Non-coding DNA wikipedia , lookup
Microsatellite wikipedia , lookup
Genome evolution wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Cre-Lox recombination wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Helitron (biology) wikipedia , lookup
Point mutation wikipedia , lookup
Microevolution wikipedia , lookup
Genomic library wikipedia , lookup
Restriction enzymes information for exam conditions essay ESSAY PLAN: 1. definitions of stuff 2. how it works 3. how it is used. 4. Conclusion: largely obsolete due to the rise of inexpensive DNA sequencing technologies Definitions Restriction enzyme mapping - determining the order of fragments produced by cutting a DNA molecule with a restriction enzyme. RFLP - restriction fragment length polymorphism, a difference in the size of a genomic DNA fragment produced by digestion with a particular enzyme. A useful DNA marker. RFLPs Restriction Fragment Length Polymorphism are markers for defined regions of the genome Used to track regions of the genome or as markers to follow traits. Can be used to track diseases in a pedigree and discover regions of the gnome where mutations might be. Both to identify whether a particular mutation is present, and to determine where in the genome mutations causing disease are located. Restriction enzyme mapping – is the technique used for detecting RFLPs, need to integrate this into the explanation below. If we take a clone of DNA we can generate a map of the DNA by digesting using restriction enzymes, and fractionating the resulting fragments on agarose gel using electrophoresis, and determining their sizes by comparison with a set of markers of known molecular weight that are run alongside the digest on the gel. This technique can be make more informative using southern blotting, where the fractionated DNA is transferred to a nylon membrane, and then specific sequences can be detected and their length determined by interrogating the membrane with a complementary DNA probe, which hybridises with the fragments, and is labelled with a radioisotope. Using RFLPs to diagnose disease: Use of RFLPs is a powerful means of diagnosing genetic disease. RFLPs: The sequence of the β Globin gene reveals that the amino acid altering mutation also changes a restriction enzyme recognition site (DdeI- the restriction enzyme- recognises the sequence CTNAG). If the DNA from both a person with and without sickle cell anaemia is digested with DdeI and then a southern blot is prepared, probed with a fragment of the beta globin gene. DNA from normal indiviudals shows two fragments, as the DdeI has been able to cleave at the restriction site, while DNA from sickle cell individuals only shows one fragment of the gene- as the mutation has resulted in the DdeI recognition site altering so that it is no longer recognised and cleaved by the enzyme. This difference in restriction digest patterns is known as Restriction Fragment Length Polymorphism (RFLP). When a mutation, such as one that results in a genetic disease, causes a change in DNA sequence that affects a restriction enzyme site, we can track this by Southern blotting. DISCOVER REGIONS OF THE GENOME WHERE MUTATIONS MAY BE LOCATED RFLPs can also be used in tracking down the genes responsible for genetic diseases. The location in the genome where the mutation is located can be identified using linkage. 2 loci on a chromosome may be separated by recombination, the further apart they are the more likely this is, but if the markers are close together the chance they will be separated by recombination is low. If the mutant gene that causes the disease is located close to upstream sites for a restriction enzyme, one of which is constant in the population, and another of which is polymorphic, varying in its position perhaps due to variable length repeat between the sites, then we can track the RFLP in a pedigree of disease transmission. If the RFLP always segregates with the disease, showing a similar pattern of inheritance, we infer it must be closely linked. This indicates that the polymorphic restriction site is close to the affected gene, and we can look in this region of the genome for candidate mutant genes that cause the disease. This technique is more effective and successful when attempting to find a gene in the entire genome, when a set of RFLPs are scattered throughout the genome, and the polymorphism is present at a reasonable frequency in the population, with large proportions of the population having different fragment lengths. USEFULNESSS: This diagnosis method can even be used to identify heterozygous carriers of recessive diseases, as in the case of sickle cell anaemia the signature Diagnostic 376bp band produced when the mutation is present will still be observed. pre-natal diagnostic parental genetic testing. Many genetic diseases may not generate useful RFLPs. 1. largely obsolete due to the rise of inexpensive DNA sequencing technologies